|
1
|
Acunzo J, Baylot V, So A and Rocchi P:
TCTP as therapeutic target in cancers. Cancer Treat Rev.
40:760–769. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bommer UA and Thiele BJ: The
translationally controlled tumour protein (TCTP). Int J Biochem
Cell Biol. 36:379–385. 2004.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Li S and Ge F: Current understanding of
the TCTP interactome. Results Probl Cell Differ. 64:127–136.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Assrir N, Malard F and Lescop E:
Structural Insights into TCTP and its interactions with ligands and
proteins. Results Probl Cell Differ. 64:9–46. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Seo EJ, Fischer N and Efferth T: Role of
TCTP for cellular differentiation and cancer therapy. Results Probl
Cell Differ. 64:263–281. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kubiak JZ and Kloc M: Elusive role of TCTP
protein and mRNA in cell cycle and cytoskeleton regulation. Results
Probl Cell Differ. 64:217–225. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Betsch L, Boltz V, Brioudes F, Pontier G,
Girard V, Savarin J, Wipperman B, Chambrier P, Tissot N, Benhamed
M, et al: TCTP and CSN4 control cell cycle progression and
development by regulating CULLIN1 neddylation in plants and
animals. PLoS Genet. 15(e1007899)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jojic B, Amodeo S and Ochsenreiter T: The
translationally controlled tumor protein TCTP is involved in cell
cycle progression and heat stress response in the bloodstream form
of Trypanosoma brucei. Microb Cell. 5:460–468. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Koziol MJ and Gurdon JB: TCTP in
development and cancer. Biochem Res Int.
2012(105203)2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chen SH, Wu PS, Chou CH, Yan YT, Liu H,
Weng SY and Yang-Yen HF: A knockout mouse approach reveals that
TCTP functions as an essential factor for cell proliferation and
survival in a tissue- or cell type-specific manner. Mol Biol Cell.
18:2525–2532. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kubiak JZ, Bazile F, Pascal A,
Richard-Parpaillon L, Polanski Z, Ciemerych MA and Chesnel F:
Temporal regulation of embryonic M-phases. Folia Histochem
Cytobiol. 46:5–9. 2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hsu YC, Chern JJ, Cai Y, Liu M and Choi
KW: Drosophila TCTP is essential for growth and proliferation
through regulation of dRheb GTPase. Nature. 445:785–788.
2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cans C, Passer BJ, Shalak V,
Nancy-Portebois V, Crible V, Amzallag N, Allanic D, Tufino R,
Argentini M, Moras D, et al: Translationally controlled tumor
protein acts as a guanine nucleotide dissociation inhibitor on the
translation elongation factor eEF1A. Proc Natl Acad Sci USA.
100:13892–13897. 2003.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bazile F, Pascal A, Arnal I, Le Clainche
C, Chesnel F and Kubiak JZ: Complex relationship between TCTP,
microtubules and actin microfilaments regulates cell shape in
normal and cancer cells. Carcinogenesis. 30:555–565.
2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tsarova K, Yarmola EG and Bubb MR:
Identification of a cofilin-like actin-binding site on
translationally controlled tumor protein (TCTP). FEBS Lett.
584:4756–4760. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mishra DK, Srivastava P, Sharma A, Prasad
R, Bhuyan SK, Malage R, Kumar P and Yadava PK: Translationally
controlled tumor protein (TCTP) is required for TGF-β1 induced
epithelial to mesenchymal transition and influences cytoskeletal
reorganization. Biochim Biophys Acta Mol Cell Res. 1865:67–75.
2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wu W, Wu B, Ye T, Huang H, Dai C, Yuan J
and Wang W: TCTP is a critical factor in shrimp immune response to
virus infection. PLoS One. 8(e74460)2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Taylor KJ, Van TT, MacDonald SM, Meshnick
SR, Fernley RT, Macreadie IG and Smooker PM: Immunization of mice
with plasmodium TCTP delays establishment of plasmodium infection.
Parasite Immunol. 37:23–31. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
MacDonald SM, Rafnar T, Langdon J and
Lichtenstein LM: Molecular identification of an IgE-dependent
histamine-releasing factor. Science. 269:688–690. 1995.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li F, Zhang D and Fujise K:
Characterization of fortilin, a novel antiapoptotic protein. J Biol
Chem. 276:47542–47549. 2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yang Y, Yang F, Xiong Z, Yan Y, Wang X,
Nishino M, Mirkovic D, Nguyen J, Wang H and Yang XF: An N-terminal
region of translationally controlled tumor protein is required for
its antiapoptotic activity. Oncogene. 24:4778–4788. 2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Bommer UA, Vine KL, Puri P, Engel M,
Belfiore L, Fildes K, Batterham M, Lochhead A and Aghmesheh M:
Translationally controlled tumour protein TCTP is induced early in
human colorectal tumours and contributes to the resistance of
HCT116 colon cancer cells to 5-FU and oxaliplatin. Cell Commun
Signal. 15(9)2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li S, Chen M, Xiong Q, Zhang J, Cui Z and
Ge F: Characterization of the translationally controlled tumor
protein (TCTP) interactome reveals novel binding partners in human
cancer cells. J Proteome Res. 15:3741–3751. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tuynder M, Susini L, Prieur S, Besse S,
Fiucci G, Amson R and Telerman A: Biological models and genes of
tumor reversion: Cellular reprogramming through tpt1/TCTP and
SIAH-1. Proc Natl Acad Sci USA. 99:14976–14981. 2002.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Amson R, Karp JE and Telerman A: Lessons
from tumor reversion for cancer treatment. Curr Opin Oncol.
25:59–65. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tuynder M, Fiucci G, Prieur S, Lespagnol
A, Géant A, Beaucourt S, Duflaut D, Besse S, Susini L, Cavarelli J,
et al: Translationally controlled tumor protein is a target of
tumor reversion. Proc Natl Acad Sci USA. 101:15364–15369.
2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Telerman A and Amson R: The molecular
programme of tumour reversion: The steps beyond malignant
transformation. Nat Rev Cancer. 9:206–216. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
28
|
Ferlay J, Colombet M, Soerjomataram I,
Mathers C, Parkin DM, Piñeros M, Znaor A and Bray F: Estimating the
global cancer incidence and mortality in 2018: GLOBOCAN sources and
methods. Int J Cancer. 144:1941–1953. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Mattiuzzi C and Lippi G: Current cancer
epidemiology. J Epidemiol Glob Health. 9:217–222. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Vasan N, Baselga J and Hyman DM: A view on
drug resistance in cancer. Nature. 575:299–309. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Miao X, Chen YB, Xu SL, Zhao T, Liu JY, Li
YR, Wang J, Zhang J and Guo GZ: TCTP overexpression is associated
with the development and progression of glioma. Tumour Biol.
34:3357–3361. 2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Amson R, Pece S, Marine JC, Di Fiore PP
and Telerman A: TPT1/ TCTP-regulated pathways in phenotypic
reprogramming. Trends Cell Biol. 23:37–46. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Chen C, Deng Y, Hua M, Xi Q, Liu R, Yang
S, Liu J, Zhong J, Tang M, Lu S, et al: Expression and clinical
role of TCTP in epithelial ovarian cancer. J Mol Histol.
46:145–156. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Michaelsen FW, Saeed ME, Schwarzkopf J and
Efferth T: Activity of Artemisia annua and artemisinin derivatives,
in prostate carcinoma. Phytomedicine. 22:1223–1231. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Koo N, Shin AY, Oh S, Kim H, Hong S, Park
SJ, Sim YM, Byeon I, Kim KY, Lim YP, et al: Comprehensive analysis
of translationally controlled tumor protein (TCTP) provides
insights for lineage-specific evolution and functional divergence.
PLoS One. 15(e0232029)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Brioudes F, Thierry AM, Chambrier P,
Mollereau B and Bendahmane M: Translationally controlled tumor
protein is a conserved mitotic growth integrator in animals and
plants. Proc Natl Acad Sci USA. 107:16384–16389. 2010.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Proietti S, Cucina A, Pensotti A, Biava
PM, Minini M, Monti N, Catizone A, Ricci G, Leonetti E, Harrath AH,
et al: Active fraction from embryo fish extracts induces reversion
of the malignant invasive phenotype in breast cancer through
down-regulation of TCTP and modulation of E-cadherin/β-catenin
pathway. Int J Mol Sci. 20(2151)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Phanthaphol N, Techasen A, Loilome W,
Thongchot S, Thanan R, Sungkhamanon S, Khuntikeo N, Yongvanit P and
Namwat N: Upregulation of TCTP is associated with
cholangiocarcinoma progression and metastasis. Oncol Lett.
14:5973–5979. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Powers S and Pollack RE: Inducing stable
reversion to achieve cancer control. Nat Rev Cancer. 16:266–270.
2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Gu X, Zheng R, Xia C, Zeng H, Zhang S, Zou
X, Yang Z, Li H and Chen W: Interactions between life expectancy
and the incidence and mortality rates of cancer in China: A
population-based cluster analysis. Cancer Commun (Lond).
38(44)2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Luengo-Fernandez R, Leal J, Gray A and
Sullivan R: Economic burden of cancer across the European Union: A
population-based cost analysis. Lancet Oncol. 14:1165–1174.
2013.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Mariotto AB, Yabroff KR, Shao Y, Feuer EJ
and Brown ML: Projections of the cost of cancer care in the United
States: 2010-2020. J Natl Cancer Inst. 103:117–128. 2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Sankaranarayanan R, Ramadas K and Qiao Yl:
Managing the changing burden of cancer in Asia. BMC Med.
12(3)2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Weber GF: DNA Damaging Drugs. In:
Molecular Therapies of Cancer. Weber GF (ed). Springer, Cham,
International Publishing, pp9-112, 2015.
|
|
45
|
Hwang SY, Chang SJ and Park BW: Does
chemotherapy really affect the quality of life of women with breast
cancer? J Breast Cancer. 16:229–235. 2013.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Lucibello M, Adanti S, Antelmi E, Dezi D,
Ciafrè S, Carcangiu ML, Zonfrillo M, Nicotera G, Sica L, De Braud F
and Pierimarchi P: Phospho-TCTP as a therapeutic target of
Dihydroartemisinin for aggressive breast cancer cells. Oncotarget.
6:5275–5291. 2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Ramani P, Nash R, Sowa-Avugrah E and
Rogers C: High levels of polo-like kinase 1 and phosphorylated
translationally controlled tumor protein indicate poor prognosis in
neuroblastomas. J Neurooncol. 125:103–111. 2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Sun R, Lu X, Gong L and Jin F: TCTP
promotes epithelial-mesenchymal transition in lung adenocarcinoma.
Onco Targets Ther. 12:1641–1653. 2019.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Rosenwald A, Wright G, Chan WC, Connors
JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland
EB, Giltnane JM, et al: The use of molecular profiling to predict
survival after chemotherapy for diffuse large-B-cell lymphoma. N
Engl J Med. 346:1937–1947. 2002.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Zhang F, Ma Q, Xu Z, Liang H, Li H, Ye Y,
Xiang S, Zhang Y, Jiang L, Hu Y, et al: Dihydroartemisinin inhibits
TCTP-dependent metastasis in gallbladder cancer. J Exp Clin Cancer
Res. 36(68)2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Xiao B, Chen D, Luo S, Hao W, Jing F, Liu
T, Wang S, Geng Y, Li L, Xu W, et al: Extracellular translationally
controlled tumor protein promotes colorectal cancer invasion and
metastasis through Cdc42/JNK/MMP9 signaling. Oncotarget.
7:50057–50073. 2016.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Bae SY, Kim HJ, Lee KJ and Lee K:
Translationally controlled tumor protein induces epithelial to
mesenchymal transition and promotes cell migration, invasion and
metastasis. Sci Rep. 5(8061)2015.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Jin H, Zhang X, Su J, Teng Y, Ren H and
Yang L: RNA interference-mediated knockdown of translationally
controlled tumor protein induces apoptosis, and inhibits growth and
invasion in glioma cells. Mol Med Rep. 12:6617–6625.
2015.PubMed/NCBI View Article : Google Scholar
|
